Summary
0I3I Chart
Medicus Pharma names Andrew Smith as COO, advances BCC and prostate drug studies
Medicus Pharma (NASDAQ:MDCX) said on Monday it has appointed Andrew Smith as chief operating officer, bringing on board a seasoned asset management executive as the company accelerates its clinical development programs in the US, Europe, and the Middle East. Smith, who most recently served as CEO of SR Asset Management until its sale in 2024, brings over 30 years of experience in financial and operational leadership.
3 Oversold Stocks Flashing Bullish Reversal Signals
When it comes to short-term trading signals, few indicators are as closely tracked as the Relative Strength Index (RSI). A stock's RSI measures the speed and magnitude of its recent price movements.
Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Cooper Companies, Inc. Dividends
 0I3I 26 Jul 2023 | Other | $0.01 Per Share |
| 0I3I 20 Jan 2023 | Other | $0.01 Per Share |
| 0I3I 26 Jul 2022 | Other | $0.01 Per Share |
| 0I3I 20 Jan 2022 | Other | $0.01 Per Share |
| 0I3I 26 Jul 2021 | Other | $0.01 Per Share |
The Cooper Companies, Inc. Earnings
| 27 Aug 2025 (In 2 months) Date | | 1.07 Cons. EPS | - EPS |
| 26 Aug 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
| 29 May 2025 Date | | - Cons. EPS | 0.44 EPS |
| 28 May 2025 Date | | - Cons. EPS | - EPS |
| 26 Feb 2025 Date | | - Cons. EPS | - EPS |
| 0I3I 26 Jul 2023 | Other | $0.01 Per Share |
| 0I3I 20 Jan 2023 | Other | $0.01 Per Share |
| 0I3I 26 Jul 2022 | Other | $0.01 Per Share |
| 0I3I 20 Jan 2022 | Other | $0.01 Per Share |
| 0I3I 26 Jul 2021 | Other | $0.01 Per Share |
| 27 Aug 2025 (In 2 months) Date | | 1.07 Cons. EPS | - EPS |
| 26 Aug 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
| 29 May 2025 Date | | - Cons. EPS | 0.44 EPS |
| 28 May 2025 Date | | - Cons. EPS | - EPS |
| 26 Feb 2025 Date | | - Cons. EPS | - EPS |
The Cooper Companies, Inc. (0I3I) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has The Cooper Companies, Inc. ever had a stock split?
The Cooper Companies, Inc. Profile
| Medical - Instruments & Supplies Industry | Healthcare Sector | Mr. Albert G. White III CEO | LSE Exchange | US2166485019 ISIN |
| US Country | 16,000 Employees | 26 Jul 2023 Last Dividend | 20 Feb 2024 Last Split | - IPO Date |
Overview
The Cooper Companies, Inc., established in 1958 and headquartered in San Ramon, California, is a global entity that specializes in the development, manufacture, and marketing of contact lenses through its subsidiaries. The operations of the company are segmented into CooperVision and CooperSurgical. CooperVision focuses on providing a variety of contact lenses including those for correcting nearsightedness, farsightedness, astigmatism, presbyopia, and myopia across various regions such as the Americas, Europe, Middle East, Africa, and Asia Pacific. On the other hand, CooperSurgical addresses family and women's health, offering a wide range of fertility products and services, medical devices, contraception, and cryostorage services for cord blood and tissue to healthcare professionals and patients globally. The products offered by The Cooper Companies, Inc. reach their end-users through distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals, clinics, and authorized resellers.
Products and Services
CooperVision:
- Spherical Lenses: These lenses are designed to correct common vision problems such as nearsightedness and farsightedness.
- Toric and Multifocal Lenses: These lenses provide solutions for more complex vision challenges, including astigmatism, presbyopia, and myopia, catering to a diverse range of contact lens wearers.
CooperSurgical:
- Fertility Products and Services: Includes consumables, equipment, donor gamete services, and genomic services such as genetic testing, designed to support the varying needs of fertility treatments.
- Medical Devices and Contraception: Ranging from Paragard contraceptive IUDs, endosee endometrial imaging, and Mara water ablation systems, these products aim to provide innovative solutions in women's healthcare and family planning.
- Cryostorage Services: Offering storage solutions for cord blood and tissue, these services play a crucial role in regenerative medicine and future health considerations.
- Surgical and Office Products: This encompasses a broad spectrum of devices and tools such as illuminated speculum products, lone star retractor systems, and fetal pillow cephalic elevation devices, used across gynecological procedures and office-based diagnostics.
Contact Information
